uniQure
Trade uniQure 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About QURE
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.
QURE Key Statistics
Stock Snapshot
With a market cap of 557.82M, uniQure(QURE) trades at $8.92. The stock has a price-to-earnings ratio of -2.60.
On 2026-03-05, uniQure(QURE) stock moved within a range of $8.92 to $9.10. With shares now at $8.92, the stock is trading 0.0% above its intraday low and -2.0% below the session's peak.
Trading volume for uniQure(QURE) stock has reached 29.99K, versus its average volume of 6.26M.
Over the past 52 weeks, uniQure(QURE) stock has traded between a high of $71.50 and a low of $7.76.
Over the past 52 weeks, uniQure(QURE) stock has traded between a high of $71.50 and a low of $7.76.
QURE News
Reports FY25 revenue $16M vs $27.119M last year. “In 2025, we presented compelling 36-month clinical data from AMT-130 that we believe meaningfully demonstrate...
Investors are focused on allegations that optimistic statements about a key Huntington’s disease program masked regulatory uncertainty until new FDA feedback em...
Analyst ratings
57%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.